Skip to content
Lower risk Medical device recall · FDA · Published February 20, 2020

RayStation/RayPlan 8B Software Update 8.1.2.5: Potential Incorrect Treatment Planning

RaySearch Laboratories recalls software version 8.1.2.5 for potential incorrect treatment planning calculations. Users should contact the company for updates.

🇺🇸 FDA recall #Z-1466-2020Medical deviceRaySearch Laboratories ›
Take action

Contact the company

Recalling firmRAYSEARCH LABORATORIES ABSveavagen 9 · Stockholm, Sweden
✎ GovInfoNow plain-language explainer

RaySearch Laboratories is recalling a specific software update for their radiation treatment planning system. This update could cause incorrect treatment calculations if pitch or roll corrections are applied, which might lead to unsafe radiation dosing. Read more at govinfonow.com/recall/65798-raystation-rayplan-8b-software-update-8-1-2-5-potential.

Source Summary by GovInfoNow · govinfonow.com/recall/65798-raystation-rayplan-8b-software-update-8-1-2-5-potential · Updated August 19, 2026 · FDA enforcement record: FDA #Z-1466-2020

Cite this page

“RayStation/RayPlan 8B Software Update 8.1.2.5: Potential Incorrect Treatment Planning.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/65798-raystation-rayplan-8b-software-update-8-1-2-5-potential. Based on FDA recall #Z-1466-2020 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1466-2020%22&limit=1).

The FDA announced on Feb. 20, 2020, that RaySearch Laboratories AB voluntarily recalled its RayStation/RayPlan 8B Service Pack 2 stand-alone software treatment planning system due to a potential for erroneous propagation of current tabletop positions. The agency said the hazard involves incorrect lateral, longitudinal and vertical values when pitch or roll correction is applied.

How to tell if you have it

  • Brand: RaySearch Laboratories
  • Product: RayStation/RayPlan 8B Service Pack 2, Build Number 8.1.2.5
  • UDI: 07350002010235
  • Quantity: 1 system in the U.S.
  • Distribution: TN

The hazard

According to the FDA, there is a potential for erroneous propagation of the current tabletop positions when applying pitch or roll correction. Even though pitch and roll correction is never propagated, non-zero pitch or roll causes the lateral, longitudinal and vertical values propagated to be incorrect.

Context

GovInfoNow's records show RaySearch Laboratories AB has 36 other recalls on record since July 17, 2017. Other recent recalls of similar products include RayCare 2:024A SP1 Oncology Software Data Loss Risk (May 20, 2026), RayStation Software Version 12A Recalls (Nov. 28, 2025), and RayStation 10B Software Version 10.1.0.613 (Aug. 8, 2025). Other recent recalls of similar products include Elekta Leksell GammaPlan software version 11.3/11.4 recall (Dec. 12, 2025), Elekta Leksell GammaPlan 11.1 Software Recall (Dec. 12, 2025), and Boston Scientific TheraSphere 360 Y-90 Software Anomaly Recall (June 19, 2026).

How to tell if you have this one

Check if you have RayStation or RayPlan software version 8B Service Pack 2 with build number 8.1.2.5. The unique device identifier (UDI) is 07350002010235.

  • Brand
    RaySearch Laboratories
  • Category
    Medical device
FDA recall event · 7 products

All 7 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    The products were distributed to the following US states: TN
Recall numberProduct, codes & lotsQuantity
Z-1462-2020RayStation/RayPlan 8A, Build Number 8.0.0.61, stand-alone software treatment planning system; UDI 073500020101121 system
Z-1463-2020RayStation/RayPlan 8A Service Pack 1, Build Number 8.0.1.10, stand-alone software treatment planning system; UDI 073500020101361 system in the U.S.
Z-1464-2020RayStation/RayPlan 8B, Build Number 8.1.0.47, stand-alone software treatment planning system; UDI 073500020101291 system in the U.S.
Z-1465-2020RayStation/RayPlan 8B Service Pack 1, Build Number 8.1.1.8, stand-alone software treatment planning system; UDI 073500020102041 system in the U.S.
Z-1466-2020RayStation/RayPlan 8B Service Pack 2, Build Number 8.1.2.5, stand-alone software treatment planning system; UDI 073500020102351 system in the U.S.
Z-1467-2020RayStation/RayPlan 9A, Build Number 9.0.0.113, stand-alone software treatment planning system; UDI 073500020101741 system in the U.S.
Z-1468-2020RayStation/RayPlan 9B, Build Number 9.1.0.933, stand-alone software treatment planning system; UDI 073500020102661 system in the U.S.
Based on the official FDA remedy

What to do — step by step

  1. Contact Manufacturer

    Reach out to RaySearch Laboratories for guidance on the specific software version and remedy.

Where it went and when

Where it was distributed

Distributed in Tennessee.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: yesTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “The products were distributed to the following US states: TN” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Tennessee.

Recall timeline

FDA terminated this recall 4.7 years after the firm started it.

1. Firm started the recall: Feb 20, 202012. FDA classified it Class II: Mar 10, 202023. Published in FDA’s Enforcement Report: Mar 18, 202034. FDA terminated the recall: Nov 5, 2024420202024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1466-2020 (February 20, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1466-2020 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA